Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,968
Total Claims
$741K
Drug Cost
625
Beneficiaries
$1,186
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1%
Cost per patient vs peers
$1,186 vs $1,174 avg
+2%
Brand preference vs peers
9.1% vs 8.9% avg
Brand vs Generic
Brand: 894 claims · $541K
Generic: 8,963 claims · $193K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Linagliptin | 36 | $52K |
| Empagliflozin | 44 | $43K |
| Semaglutide | 33 | $37K |
| Sitagliptin Phosphate | 21 | $35K |
| Apixaban | 40 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 74 | $31K |
| Sacubitril/Valsartan | 19 | $21K |
| Dulaglutide | 18 | $20K |
| Linaclotide | 32 | $18K |
| Ticagrelor | 21 | $16K |
| Budesonide/Formoterol Fumarate | 40 | $16K |
| Insulin Lispro | 22 | $12K |
| Insulin Detemir | 15 | $9,692 |
| Insulin Aspart | 18 | $8,374 |
| Cyclosporine | 11 | $7,602 |
Prescribing Profile
Patient Profile
72
Avg Age
47%
Female
1.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data